cherdchai chawienghong/iStock via Getty Images The following segment was excerpted from this fund letter. Top Holdings Our top five investments represented roughly 50% of the equity portfolio at quarter end. In alphabetical order, they were Avantor (AVTR), Baxter (BAX), Fiserv (FI), Nintendo (OTCPK:NTDOY), and Philip Morris (PM). Three of these five weighed on performance most heavily in the second quarter. And just the same, four of the top five were the fund’s largest contributors in July. As there wa ...

EcoVadis Rating validates Avantor's business sustainability commitments and performanceRADNOR, Pa., Sept. 12, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced today, for the second year in a row, that the Company has been awarded a Bronze Medal from EcoVadis, a global leader in business sustainability assessments.Avantor's latest score of 65, which was awarded ...

RADNOR, Pa., Aug. 22, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5, at approximately 10:45 a.m. Eastern Daylight Time.To hear a live audio webcast of the session, visit Even ...

Avantor, Inc. (AVTR) recently signed a definitive agreement to divest its clinical services business, including kitting, biorepository, and related equipment and ancillaries (collectively known as Clinical Services), to Audax Private Equity (Audax). The transaction is expected to close in the fourth quarter of 2024, subject to regulatory approvals and other customary closing conditions.The clinical services business is currently part of Avantor's Laboratory Solutions segment.Avantor’s management plans to di ...

Accelerates ongoing business transformation and sharpens Avantor's strategic focus Strengthens balance sheet with proceeds to be used for debt paydownRADNOR, Pa., Aug. 16, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the signing of a definitive agreement to divest its clinical services business, including kitting, biorepository, and related equipment ...

Avantor, Inc. (AVTR) reported second-quarter 2024 adjusted earnings per share (EPS) of 25 cents, down 10.7% year over year. The bottom line however surpassed the Zacks Consensus Estimate by 2%.GAAP EPS for the quarter was 14 cents against a loss of 1 cent in the year-ago period.Revenue DetailsRevenues grossed $1.7 billion in the reported quarter, down 2.4% year over year. The metric also missed the Zacks Consensus Estimate.Foreign currency translation had a negative impact of 0.4% in the reported quarter, r ...

Avantor, Inc. AVTR reported better-than-expected second-quarter earnings results on Friday.Avantor posted adjusted earnings of 25 cents per share, beating market estimates of 23 cents per share. The company posted sales of $1.703 billion, in-line with estimates, according to data from Benzinga Pro.“Our teams delivered another solid quarter with sequential improvements to all key financial metrics. Improved mix from increased bioprocessing revenue together with the accelerated impact of our cost transformati ...

(Vavantor™ Q2 2024 Earnings EARNINGS PRESENTATION July 26, 2024 AVTR LISTED NYSE Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking s ...

Avantor Inc. (NYSE:AVTR) Q2 2024 Earnings Conference Call July 26, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President & CEO Brent Jones - EVP & CFO Conference Call Participants Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Douglas Schenkel - Wolfe Research Daniel Brennan - TD Cowen Rachel Vatnsdal - JPMorgan Michael Ryskin - Bank of America Jack Meehan - Nephron Research Matthew Sykes - Goldman Sachs Conor McNamara - RBC Capital Markets Luke Sergott - Barc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ━━━━━━━━━ FORM 10-Q ━━━━━━━━━ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-38912 Avantor, Inc. (Exact name of registrant as specified in its charter) Delaware 82-2758923 (Stat ...